Publicacións en colaboración con investigadores/as de Institut d'Investigació Biomédica de Bellvitge (3)

2023

  1. Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study

    PLoS ONE, Vol. 18, Núm. 8 August

2022

  1. Comparison of three short-course rifamycinbased regimens for the prevention of tuberculosis in patients with end-stage kidney disease: Study protocol for a randomised clinical trial (RIFAKiD-TB trial)

    PLoS ONE, Vol. 17, Núm. 10 October

2021

  1. Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study

    Microbiology Spectrum, Vol. 9, Núm. 3